about
Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiformeTwo Patients With Brain Tumors Who Received Bevacizumab and Radiotherapy: Optic Neuropathy and Quality-of-Life IssuesGlioma cancer stem cells secrete Gremlin1 to promote their maintenance within the tumor hierarchy.Bevacizumab plus ipilimumab in patients with metastatic melanoma.The challenges and the promise of molecular targeted therapy in malignant gliomas.The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiformeBevacizumab treatment of symptomatic pseudoprogression after boron neutron capture therapy for recurrent malignant gliomas. Report of 2 cases.Synergistic inhibition of angiogenesis and glioma cell-induced angiogenesis by the combination of temozolomide and enediyne antibiotic lidamycin.Refined brain tumor diagnostics and stratified therapies: the requirement for a multidisciplinary approach.Long-Term Survival and Improved Quality of Life following Multiple Repeat Gamma Knife Radiosurgeries for Recurrent Glioblastoma Multiforme: A Case Report and Review of the Literature.Association of dynamic susceptibility contrast enhanced MR Perfusion parameters with prognosis in elderly patients with glioblastomas.Early perfusion MRI predicts survival outcome in patients with recurrent glioblastoma treated with bevacizumab and carboplatin.Correlation between ¹⁸F-fluoromisonidazole PET and expression of HIF-1α and VEGF in newly diagnosed and recurrent malignant gliomas.Apatinib suppresses cell growth and metastasis and promotes antitumor activity of temozolomide in glioma
P2860
Q26824557-6890A4F3-882F-446D-9287-009B297EFBD3Q26853684-5DD63DAE-D3C6-4CA3-AB4F-28076243BE4CQ33671783-08E7CCA5-73E2-4E17-9FF8-D24AE6D6212EQ35012765-4A43A23B-05FE-4A70-8D3B-18F79888F4C7Q35214534-D8147B33-EA46-404C-B751-7A845FF33A41Q35770218-B8388970-BE2B-4141-BA96-9A6ACE325BEAQ36866038-A894F08E-63D0-4ADB-9629-73364AC0ADC4Q37692451-F69EA65F-5E0D-4136-BDF3-5B0ADEA47833Q38108186-C6E455BB-9129-475F-A9C4-349D1B9A12C0Q38156790-61D6BCBF-95AE-46E4-AF90-0D2AC1AA58FFQ41438064-3B6FD300-6C5D-4221-ADDA-FC1A8A8D51B0Q48192001-C85F1C00-C6FF-4178-8AA2-08546595175EQ55460951-32D3F5A0-1D22-4A39-8F29-401A91A4E7C8Q57788828-6F3F5DD8-A849-4776-9FF6-E5802D2F1297
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Bevacizumab for the treatment of high-grade glioma.
@en
type
label
Bevacizumab for the treatment of high-grade glioma.
@en
prefLabel
Bevacizumab for the treatment of high-grade glioma.
@en
P2860
P1476
Bevacizumab for the treatment of high-grade glioma
@en
P2093
Marcelle Simeonovic
P2860
P304
P356
10.1517/14712598.2012.694422
P407
P577
2012-06-05T00:00:00Z